within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M04A_AntigoutPreparations.M04AA03_Febuxostat;
model Febuxostat 
   extends Pharmacolibrary.Drugs.ATC.M.M04AA03;

  annotation(Documentation(
    info ="<html><body><p>Febuxostat is a non-purine selective inhibitor of xanthine oxidase, used primarily for the treatment of chronic hyperuricemia in patients with gout. It is an orally administered medication approved in many countries, though its use may be restricted in some regions due to cardiovascular concerns.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Kamel, B, et al., &amp; Day, RO (2017). Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat. <i>Clinical pharmacokinetics</i> 56(5) 459–475. DOI:<a href=&quot;https://doi.org/10.1007/s40262-016-0466-4&quot;>10.1007/s40262-016-0466-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27753003/&quot;>https://pubmed.ncbi.nlm.nih.gov/27753003</a></p></li><li><p>Zhou, H, et al., &amp; Shentu, J (2016). Pharmacokinetics and tolerability of febuxostat after oral administration in healthy Chinese volunteers: a randomized, open-label, singleand multiple-dose three-way crossover study. <i>International journal of clinical pharmacology and therapeutics</i> 54(2) 115–124. DOI:<a href=&quot;https://doi.org/10.5414/CP202394&quot;>10.5414/CP202394</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26636422/&quot;>https://pubmed.ncbi.nlm.nih.gov/26636422</a></p></li><li><p>Zhang, M, et al., &amp; Xu, X (2014). Pharmacokinetics and pharmacodynamics of febuxostat under fasting conditions in healthy individuals. <i>Experimental and therapeutic medicine</i> 7(2) 393–396. DOI:<a href=&quot;https://doi.org/10.3892/etm.2013.1414&quot;>10.3892/etm.2013.1414</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24396412/&quot;>https://pubmed.ncbi.nlm.nih.gov/24396412</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Febuxostat;
